XP13512 Shows Promising Results in Restless Legs Syndrome: Presented at AAPM
By Emma Hitt, PhD
HONOLULU -- February 2, 2009 -- An experimental treatment for restless legs syndrome (RLS), XP13512, was found to improve symptoms in all patients and reduced pain associated with RLS compared with placebo, according to results of a study presented here at the American Academy of Pain Medicine (AAPM) 25th Annual Meeting."Pain is not a criterion for diagnosis of RLS, but many patients report ...
To read more, click here.
Tuesday, February 3, 2009
Potential New Drug for RLS
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment